211 related articles for article (PubMed ID: 22138416)
1. Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment.
Ricker LJ; Kijlstra A; Kessels AG; de Jager W; Hendrikse F; La Heij EC
Exp Eye Res; 2012 Jan; 94(1):56-62. PubMed ID: 22138416
[TBL] [Abstract][Full Text] [Related]
2. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
[TBL] [Abstract][Full Text] [Related]
3. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
[TBL] [Abstract][Full Text] [Related]
4. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.
Ricker LJ; Altara R; Goezinne F; Hendrikse F; Kijlstra A; La Heij EC
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4256-62. PubMed ID: 21372012
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2012 Jul; 59(1):184-90. PubMed ID: 22579111
[TBL] [Abstract][Full Text] [Related]
6. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
[TBL] [Abstract][Full Text] [Related]
7. Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
Symeonidis C; Papakonstantinou E; Souliou E; Karakiulakis G; Dimitrakos SA; Diza E
Acta Ophthalmol; 2011 Jun; 89(4):339-45. PubMed ID: 19764916
[TBL] [Abstract][Full Text] [Related]
8. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
[TBL] [Abstract][Full Text] [Related]
9. S100b protein levels in subretinal fluid in rhegmatogenous retinal detachment.
Yalcinbayir O; Buyukuysal RL; Akova-Budak B; Gelisken O
Curr Eye Res; 2012 Nov; 37(11):1030-5. PubMed ID: 22671138
[TBL] [Abstract][Full Text] [Related]
10. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
11. [Surgical therapeutic results of rhegmatogenous retinal detachment associated with choroidal detachment].
Zhu J; Xu X; Zhang X
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):135-9. PubMed ID: 11955315
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC
Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for surgical failures in rhegmatogenous retinal detachment].
Mangouritsas G; Rothbächer HH; Heidenkummer PH; Ulbig MW; Kampik A
Klin Monbl Augenheilkd; 1995 Jan; 206(1):20-8. PubMed ID: 7897964
[TBL] [Abstract][Full Text] [Related]
14. Conventional retinal surgery for rhegmatogenous retinal detachment with proliferative vitreoretinopathy.
Ivanisević M
Acta Med Croatica; 1995; 49(4-5):207-9. PubMed ID: 8630455
[TBL] [Abstract][Full Text] [Related]
15. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.
Symeonidis C; Androudi S; Rotsos T; Moschos MM; Souliou E; Dimitrakos SA; Diza E
Ocul Immunol Inflamm; 2014 Dec; 22(6):449-53. PubMed ID: 24354433
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
17. Primary vitrectomy versus conventional retinal detachment surgery in phakic rhegmatogenous retinal detachment.
Azad RV; Chanana B; Sharma YR; Vohra R
Acta Ophthalmol Scand; 2007 Aug; 85(5):540-5. PubMed ID: 17355251
[TBL] [Abstract][Full Text] [Related]
18. Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment.
Yeung L; Yang KJ; Chen TL; Wang NK; Chen YP; Ku WC; Lai CC
Acta Ophthalmol; 2008 Mar; 86(2):165-9. PubMed ID: 17995984
[TBL] [Abstract][Full Text] [Related]
19. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
Kon CH; Occleston NL; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
[TBL] [Abstract][Full Text] [Related]
20. Management of retinal detachment when no break is found.
Salicone A; Smiddy WE; Venkatraman A; Feuer W
Ophthalmology; 2006 Mar; 113(3):398-403. PubMed ID: 16406538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
